Corvus Pharmaceuticals Inc (CRVS)
8.95
+0.01
(+0.11%)
USD |
NASDAQ |
Nov 22, 16:00
8.96
+0.01
(+0.11%)
After-Hours: 20:00
Corvus Pharmaceuticals Market Cap: 575.10M for Nov. 22, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 22, 2024 | 575.10M |
| November 21, 2024 | 574.46M |
| November 20, 2024 | 529.48M |
| November 19, 2024 | 539.76M |
| November 18, 2024 | 535.91M |
| November 15, 2024 | 526.27M |
| November 14, 2024 | 547.47M |
| November 13, 2024 | 569.96M |
| November 12, 2024 | 558.40M |
| November 11, 2024 | 598.26M |
| November 08, 2024 | 591.38M |
| November 07, 2024 | 550.70M |
| November 06, 2024 | 549.45M |
| November 05, 2024 | 577.61M |
| November 04, 2024 | 564.47M |
| November 01, 2024 | 569.48M |
| October 31, 2024 | 553.21M |
| October 30, 2024 | 550.70M |
| October 29, 2024 | 556.34M |
| October 28, 2024 | 540.69M |
| October 25, 2024 | 520.04M |
| October 24, 2024 | 480.61M |
| October 23, 2024 | 473.10M |
| October 22, 2024 | 485.00M |
| October 21, 2024 | 473.10M |
| Date | Value |
|---|---|
| October 18, 2024 | 451.20M |
| October 17, 2024 | 451.20M |
| October 16, 2024 | 459.96M |
| October 15, 2024 | 420.54M |
| October 14, 2024 | 424.92M |
| October 11, 2024 | 396.13M |
| October 10, 2024 | 363.59M |
| October 09, 2024 | 374.85M |
| October 08, 2024 | 371.73M |
| October 07, 2024 | 347.94M |
| October 04, 2024 | 352.95M |
| October 03, 2024 | 329.17M |
| October 02, 2024 | 330.42M |
| October 01, 2024 | 318.53M |
| September 30, 2024 | 330.42M |
| September 27, 2024 | 322.14M |
| September 26, 2024 | 318.39M |
| September 25, 2024 | 325.27M |
| September 24, 2024 | 324.02M |
| September 23, 2024 | 340.28M |
| September 20, 2024 | 369.68M |
| September 19, 2024 | 350.91M |
| September 18, 2024 | 342.78M |
| September 17, 2024 | 344.03M |
| September 16, 2024 | 361.55M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
30.18M
Minimum
Mar 28 2023
598.26M
Maximum
Nov 11 2024
113.64M
Average
101.51M
Median
Market Cap Benchmarks
| Azenta Inc | 2.058B |
| Perspective Therapeutics Inc | 234.53M |
| Atara Biotherapeutics Inc | 66.06M |
| Clearside Biomedical Inc | 81.91M |
| Quanterix Corp | 450.95M |
Market Cap Related Metrics
| Price to Book Value | 46.35 |
| Price | 8.95 |
| Earnings Yield | -10.28% |